Mitochondrial dysfunction generates aggregates that resist lysosomal degradation in human breast cancer cells

scientific article published on 15 June 2020

Mitochondrial dysfunction generates aggregates that resist lysosomal degradation in human breast cancer cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41419-020-2658-Y
P932PMC publication ID7296005
P698PubMed publication ID32541677

P2093author name stringNaoko Mizuno
Baikuntha Aryal
Michael H Gerber
V Ashutosh Rao
Thomas G Biel
Josè G Trevino
P2860cites workLoss of Mitochondrial Function Impairs Lysosomes.Q38785393
Proteasomal and Autophagic Degradation SystemsQ39275553
The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with BortezomibQ39856430
Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefitsQ40359103
Enhanced Degradation of Misfolded Proteins Promotes Tumorigenesis.Q41720019
Targeting autophagy in cancerQ41912265
Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cellsQ47150116
The proteasome and proteasome inhibitors in multiple myelomaQ47339695
Receptor oligomerization guides pathway choice between proteasomal and autophagic degradation.Q48144486
Mitochondrial dysfunction activates lysosomal-dependent mitophagy selectively in cancer cells.Q49304282
Metabolic effects of fasting on human and mouse blood in vivo.Q49970544
Cargo recognition and degradation by selective autophagy.Q50422083
A brief history of autophagy from cell biology to physiology and disease.Q52568575
Changes in contraction, cytosolic Ca2+ and pH during metabolic inhibition and upon restoration of mitochondrial respiration in rat ventricular myocytes.Q52867033
Co-localization of mutant p53 and amyloid-like protein aggregates in breast tumorsQ57084696
Mitochondrial metabolism and cancerQ57842307
An agarose-acrylamide composite native gel system suitable for separating ultra-large protein complexesQ81889891
p53 protein aggregation promotes platinum resistance in ovarian cancerQ85645987
Pharmacological targeting of mutant p53Q92914764
Genevestigator v3: a reference expression database for the meta-analysis of transcriptomesQ21342839
Guidelines for the use and interpretation of assays for monitoring autophagyQ21996341
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Q22676705
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotesQ23757358
Micro-flow imaging: flow microscopy applied to sub-visible particulate analysis in protein formulationsQ24622866
Mito-tempol and dexrazoxane exhibit cardioprotective and chemotherapeutic effects through specific protein oxidation and autophagy in a syngeneic breast tumor preclinical modelQ27310238
A lysosome-centered view of nutrient homeostasisQ28073435
Protein aggregation as a cellular response to oxidative stress induced by heme and ironQ28395171
CBP/p300 Bromodomains Regulate Amyloid-like Protein Aggregation upon Aberrant Lysine AcetylationQ28818241
Aggresomes, inclusion bodies and protein aggregationQ29615253
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiformeQ33416266
The accumulation of misfolded proteins in the mitochondrial matrix is sensed by PINK1 to induce PARK2/Parkin-mediated mitophagy of polarized mitochondriaQ33638683
Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinomaQ33699665
The small heat shock protein B8 (HSPB8) confers resistance to bortezomib by promoting autophagic removal of misfolded proteins in multiple myeloma cells.Q34227679
The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinoneQ34251106
Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myelomaQ34372977
Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumorsQ34372994
TBK1 kinase addiction in lung cancer cells is mediated via autophagy of Tax1bp1/Ndp52 and non-canonical NF-κB signallingQ34500600
Autophagy and human disease: emerging themesQ34620377
Engineering trimeric fibrous proteins based on bacteriophage T4 adhesinsQ34663520
Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma.Q35550181
Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapyQ35960231
Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer.Q36201740
Therapeutic Targeting of the Mitochondria Initiates Excessive Superoxide Production and Mitochondrial Depolarization Causing Decreased mtDNA IntegrityQ36234714
The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagyQ37246125
Genevestigator transcriptome meta-analysis and biomarker search using rice and barley gene expression databasesQ38508703
Cytosolic proteostasis through importing of misfolded proteins into mitochondriaQ38714671
Molecular definitions of autophagy and related processes.Q38735356
P433issue6
P304page(s)460
P577publication date2020-06-15
P1433published inCell Death and DiseaseQ2197222
P1476titleMitochondrial dysfunction generates aggregates that resist lysosomal degradation in human breast cancer cells
P478volume11

Search more.